Sinusoidal obstruction syndrome/veno-occlusive disease: current situation and perspectives—a position statement from the European Society for Blood and Marrow …

M Mohty, F Malard, M Abecassis, E Aerts… - Bone marrow …, 2015 - nature.com
Sinusoidal obstruction syndrome or veno-occlusive disease (SOS/VOD) is a potentially life-
threatening complication of hematopoietic SCT (HSCT). This review aims to highlight, on …

The role of the endothelium in the short-term complications of hematopoietic SCT

E Carreras, M Diaz-Ricart - Bone marrow transplantation, 2011 - nature.com
In this review, we analyse the role of the endothelium in the development of several
complications that appear soon after haematopoietic SCT (HSCT). Once it had been …

[HTML][HTML] NIH Consensus development project on criteria for clinical trials in chronic graft-versus-host disease: II. The 2014 Pathology Working Group Report

HM Shulman, DM Cardona, JK Greenson… - Biology of Blood and …, 2015 - Elsevier
Abstract The 2005 National Institute of Health (NIH) Consensus Conference outlined
histopathological diagnostic criteria for the major organ systems affected by both acute and …

How I manage sinusoidal obstruction syndrome after haematopoietic cell transplantation

E Carreras - British journal of haematology, 2015 - Wiley Online Library
Sinusoidal obstruction syndrome (SOS), also called veno‐occlusive disease of the liver, is
one of the most relevant complications of endothelial origin that appears early after …

[HTML][HTML] The incidence of veno-occlusive disease following allogeneic hematopoietic stem cell transplantation has diminished and the outcome improved over the last …

E Carreras, M Díaz-Beyá, L Rosiñol, C Martínez… - Biology of blood and …, 2011 - Elsevier
The evolution of the incidence, morbidity, and mortality of veno-occlusive disease (VOD)
was analyzed in 845 allogeneic hematopoietic stem cell transplantations (allo-HSCTs) …

Milestones of hematopoietic stem cell transplantation–from first human studies to current developments

MK Juric, S Ghimire, J Ogonek, EM Weissinger… - Frontiers in …, 2016 - frontiersin.org
Since the early beginnings, in the 1950s, hematopoietic stem cell transplantation (HSCT)
has become an established curative treatment for an increasing number of patients with life …

Distinctive biomarker features in the endotheliopathy of COVID-19 and septic syndromes

S Fernández, AB Moreno-Castaño, M Palomo… - Shock, 2022 - journals.lww.com
Background: Endotheliopathy is a key element in COVID-19 pathophysiology, contributing to
both morbidity and mortality. Biomarkers distinguishing different COVID-19 phenotypes from …

Haplo‐identical transplantation for acquired severe aplastic anaemia in a multicentre prospective study

LP Xu, SQ Wang, DP Wu, JM Wang… - British journal of …, 2016 - Wiley Online Library
We conducted a prospective, multicentre study to confirm the feasibility of haplo‐identical
transplantation in treatment of severe aplastic anaemia (SAA) as salvage therapy, by …

Hematopoietic stem cell transplant-associated thrombotic microangiopathy: current paradigm and novel therapies

J Khosla, AC Yeh, TR Spitzer, BR Dey - Bone marrow transplantation, 2018 - nature.com
Hematopoietic stem cell transplantation-associated thrombotic microangiopathy (TA-TMA)
remains a difficult complication to address due to its high mortality rate, lack of standard …

Endothelial cell function and endothelial‐related disorders following haematopoietic cell transplantation

GC Hildebrandt, N Chao - British Journal of Haematology, 2020 - Wiley Online Library
Use of haematopoietic cell transplantation (HCT) in the treatment of haematologic and
neoplastic diseases may lead to life‐threatening complications that cause substantial …